The global bone growth stimulators market was valued at $1,242 million in 2018, and is estimated to reach at $1,869 million by 2026, registering a CAGR of 5.2% from 2019 to 2026.
Top Companies Covered in this Report: Arthrex, Inc., Essex Woodlands Healthcare Partners (Bioventus LLC), Colfax Corporation (DJO Global, Inc), Isto Biologics, Johnson & Johnson (Depuy Synthes), Medtronic PLC, Orthofix Medical Inc., Stryker Corporation, Terumo Corporation, Zimmer Biomet Holdings, Inc.
Get sample copy of Report at:
Bone growth stimulators are used for bone growth, which also aid in broken bone healing process. Bone growth stimulators help in production of new bone cells and work in case of all fractures. In addition, it is used for healing of long leg bones such as tibia and in surgical procedures such as spinal fusions, which are difficult to heal. Bone growth stimulators include bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma.
Rise in number of trauma and accident cases, increase in prevalence of arthritis, surge in inclination of patients toward minimally invasive & non-invasive surgical treatments, rise in geriatric population, and rapid demand and adoption of platelet-rich plasma and bone morphogenetic proteins are some factors that fuel the growth of the bone growth stimulators market. In addition, rise in cases of diabetes and other medical conditions such as obesity, vascular disease, and renal disorders are also expected to drive the market during the forecast period. Moreover, bone growth stimulation products offer more benefits compared to traditional surgical therapies such as cost-effective and safe alternative mode to treat orthopedic diseases and bone fracture treatment. However, stringent approval process and limited medical reimbursement policies for bone stimulation products are expected to hinder the growth of the market.
The bone growth stimulators market is segmented into product, application, distribution channel, and region. By product, it is categorized into bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma. Depending on application, it is classified into spinal fusion surgeries, delayed union & nonunion bone fractures, oral & maxillofacial surgeries, and others. By distribution channel, it is divided into hospitals & clinics, home care, and others. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Get Discount for This Report https://www.premiummarketinsights.com/discount/AMR00026894
Table Of Content
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: BONE GROWTH STIMULATORS TREATMENT MARKET, BY PRODUCT
CHAPTER 5: BONE GROWTH STIMULATORS TREATMENT MARKET, BY APPLICATION
CHAPTER 6: BONE GROWTH STIMULATORS TREATMENT MARKET, BY DISTRIBUTION CHANNEL
CHAPTER 7: BONE GROWTH STIMULATORS MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
Enquire about report at: https://www.premiummarketinsights.com/buy/AMR00026894
About Premium Market Insights:
Premiummarketinsights.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Email: [email protected]